Summary

The global neoplasm treatment market is expected to grow at a significant rate of around 8% during the forecast period. Neoplasm refers to the abnormal growth of tissue caused by the rapid division of cells that have undergone some form of mutation. In this condition, the group of cells grows in an uncoordinated manner with the surrounding cells and can cause damage to the tissues surrounding them. The rising geriatric population and high risk of cancer in old-aged attributes to the growth of the neoplasm treatment market. For instance, according to the World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or over and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion).

Eisai Co., Ltd.; Exelixis, Inc.; Thermo Fisher Scientific; Boehringer Ingelheim International GmbH; Bayer AG; Abbott; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd; Siemens Healthcare GmbH.; and Novartis AG are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst Type, benign category to grow with the considerable rate during the forecast period.”
Based on the type, the market has been categorized into malignant and benign. Among them, the benign segment is expected to grow at a considerable rate in the market. Benign tumors are considered the most common form of the tumor and their rising number attributes to the growth of the segment. For instance, as per the office on women’s health, about 20 percent to 80 percent of women develop fibroids by the time they reach age 50. Fibroids are most common in women in their 40s and early 50s.

“Amongst Treatment Type, the chemotherapy segment held the dominant share in the market in 2020.”
Based on the treatment type, the market has been categorized into surgery, chemotherapy, targeted therapy, and others. Among them, the chemotherapy segment held the dominant share in 2020. Chemotherapy is more cost-efficient and minimally invasive procedure, which acts as a key factor responsible for its high adoption among cancer patients. Furthermore, the rising prevalence of oncological disorders and the increasing demand for cost-efficient treatment is also important to factor for the market growth of the segment.

“Amongst End-User, specialty clinics segment to hold a higher CAGR during the forecast period”
Based on the end-user, the market has been categorized into hospitals, cancer research centers, specialty clinics, and others. Among them, the specialty clinics segment holds a higher CAGR during the forecast period. The rising prevalence of cancer and the favorable government policies along with the presence of specialized professionals in the specialty centers attributes to the growth of the segment in the market.

“Asia Pacific to witness the fastest growth in the market”
Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as rising medical expenditure, increasing disposable income of people, along with continuously rising population of cancer patients in the region attributes to the market growth of neoplasm treatments in the region. For instance, according to the Indian Council of Medical Research (ICMR), the estimated number of people with cancer was around 2.7 million in 2020, and every year number of new cancer patients registered accounted for 13.9 lakhs.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global Neoplasm Treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents